AG-013736, a multitarget tyrosine kinase receptor inhibitor, demonstrates anti-tumor activity in a phase 2 study of cytokine-refractory, metastatic renal cell cancer (RCC)
収録刊行物
-
- ASCO Proc, 2005
-
ASCO Proc, 2005 2005